Page 26 - 《中国药科大学学报》2025年第4期

422 学报 Journal of China Pharmaceutical University 2025, 56(4): 416 − 423 第 56 卷

ruption[A]. 31 March 2025, PREPRINT (Version 1) available at
References
Research Square.
[1] Cohen D, Melamed S, Millman A, et al. Cyclic GMP-AMP sig- [17] Wang JG, Li Z, Lang H, et al. Cyclic-dinucleotide-induced fila-
nalling protects bacteria against viral infection[J]. Nature, 2019, mentous assembly of phospholipases governs broad CBASS im-
574(7780): 691-695. munity[J]. Cell, 2025: S0092-8674(25)00457-X.
[2] Millman A, Melamed S, Amitai G, et al. Diversity and classifi- [18] Chakravarti A, Patel DJ. Structure-guided insights into TIR-me-
cation of cyclic-oligonucleotide-based anti-phage signalling sys- diated bacterial and eukaryotic immunity[J]. Structure,2025,
tems[J]. Nat Microbiol, 2020, 5(12): 1608-1615. 33(3): 421-434.
[3] Lowey B, Whiteley AT, Keszei AFA, et al. CBASS immunity [19] Rousset F, Yirmiya E, Nesher S, et al. A conserved family of
uses CARF-related effectors to sense 3'-5'- and 2'-5'-linked immune effectors cleaves cellular ATP upon viral infection[J].
cyclic oligonucleotide signals and protect bacteria from phage Cell, 2023, 186(17): 3619-3631. e13.
infection[J]. Cell, 2020, 182(1): 38-49. e17. [20] Ledvina HE, Ye QZ, Gu YJ, et al. An E1-E2 fusion protein
[4] Govande AA, Duncan-Lowey B, Eaglesham JB, et al. Molecu- primes antiviral immune signalling in bacteria[J]. Nature, 2023,
lar basis of CD-NTase nucleotide selection in CBASS anti- 616(7956): 319-325.
phage defense[J]. Cell Rep, 2021, 35(9): 109206. [21] Yan Y, Xiao J, Huang FT, et al. Phage defence system CBASS
[5] Banh DV, Roberts CG, Morales-Amador A, et al. Bacterial is regulated by a prokaryotic E2 enzyme that imitates the ubiq-
cGAS senses a viral RNA to initiate immunity[J]. Nature, 2023, uitin pathway[J]. Nat Microbiol, 2024, 9(6): 1566-1578.
623(7989): 1001-1008. [22] Li FQ, Ma CY, Ding X, et al. Structural and functional charac-
[6] Richmond-Buccola D, Hobbs SJ, Garcia JM, et al. A large-scale terization of the bacterial Cap3 enzyme in deconjugation and
type I CBASS antiphage screen identifies the phage prohead regulation of the cyclic dinucleotide transferase CD-NTase[J].
protease as a key determinant of immune activation and eva- Biochem Biophys Res Commun, 2024, 727: 150326.
sion[J]. Cell Host Microbe, 2024, 32(7): 1074-1088. e5. [23] Jenson JM, Li T, Du FH, et al. Ubiquitin-like conjugation by
[7] Brenzinger S, Airoldi M, Ogunleye AJ, et al. The Vibrio choler- bacterial cGAS enhances anti-phage defence[J]. Nature, 2023,
ae CBASS phage defence system modulates resistance and 616(7956): 326-331.
killing by antifolate antibiotics[J]. Nat Microbiol,2024,9(1): [24] Keith NC, Snyder RA, Euler CW, et al. Bacteria exploit viral
251-262. dormancy to establish CRISPR-Cas immunity[J]. Cell Host Mi-
[8] Severin GB, Ramliden MS, Ford KC, et al. Activation of a Vib- crobe, 2025, 33(3): 330-340. e6.
rio cholerae CBASS anti-phage system by quorum sensing and [25] Barrangou R, Fremaux C, Deveau H, et al. CRISPR provides
folate depletion[J]. mBio, 2023, 14(5): e0087523. acquired resistance against viruses in prokaryotes[J]. Science,
[9] Lau RK, Enustun E, Gu YJ, et al. A conserved signaling path- 2007, 315(5819): 1709-1712.
way activates bacterial CBASS immune signaling in response to [26] van der Oost J, Westra ER, Jackson RN, et al. Unravelling the
DNA damage[J]. EMBO J, 2022, 41(22): e111540. structural and mechanistic basis of CRISPR-Cas systems[J]. Nat
[10] Rechkoblit O, Sciaky D, Kreitler DF, et al. Activation of Rev Microbiol, 2014, 12(7): 479-492.
CBASS Cap5 endonuclease immune effector by cyclic nu- [27] Tamulaitiene G, Sabonis D, Sasnauskas G, et al. Activation of
cleotides[J]. Nat Struct Mol Biol, 2024, 31(5): 767-776. Thoeris antiviral system via SIR2 effector filament assembly[J].
[11] Fatma S, Chakravarti A, Zeng XK, et al. Molecular mecha- Nature, 2024, 627(8003): 431-436.
nisms of the CdnG-Cap5 antiphage defense system employing [28] Antine SP, Johnson AG, Mooney SE, et al. Structural basis of
3’, 2’-cGAMP as the second messenger[J]. Nat Commun, 2021, Gabija anti-phage defence and viral immune evasion[J]. Nature,
12: 6381. 2024, 625(7994): 360-365.
[12] Chang JJ, You BJ, Ni TE, et al. Specific recognition of cyclic [29] Hu HD, Popp PF, Hughes TCD, et al. Structure and mechanism
oligonucleotides by Cap4 for phage infection[J]. Int J Biol of the Zorya anti-phage defence system[J]. Nature, 2025,
Macromol, 2023, 237: 123656. 639(8056): 1093-1101.
[13] Liang QS, Richey ST, Ur SN, et al. Structure and activity of a [30] Tal N, Morehouse BR, Millman A, et al. Cyclic CMP and cyclic
bacterial defense-associated 3'-5' exonuclease[J]. Protein Sci, UMP mediate bacterial immunity against phages[J]. Cell, 2021,
2022, 31(7): e4374. 184(23): 5728-5739. e16.
[14] Lau RK, Ye QZ, Birkholz EA, et al. Structure and mechanism [31] Zhang XW, Bai XC, Chen ZJ. Structures and mechanisms in the
of a cyclic trinucleotide-activated bacterial endonuclease medi- cGAS-STING innate immunity pathway[J]. Immunity, 2020,
ating bacteriophage immunity[J]. Mol Cell, 2020, 77(4): 723- 53(1): 43-53.
733. e6. [32] Burdette DL, Monroe KM, Sotelo-Troha K, et al. STING is a
[15] Duncan-Lowey B, McNamara-Bordewick NK, Tal N, et al. Ef- direct innate immune sensor of cyclic di-GMP[J]. Nature, 2011,
fector-mediated membrane disruption controls cell death in 478(7370): 515-518.
CBASS antiphage defense[J]. Mol Cell, 2021, 81(24): 5039- [33] Kato K, Ishii R, Hirano S, et al. Structural basis for the catalyt-
5051. e5. ic mechanism of DncV, bacterial homolog of cyclic GMP-AMP
[16] Xiao Y, Kong J, Wu W, et al. Molecular mechanisms of synthase[J]. Structure, 2015, 23(5): 843-850.
CBASS phospholipase effector CapV mediated membrane dis- [34] Morehouse BR, Govande AA, Millman A, et al. STING cyclic